Citigroup
KMTS

Citigroup’s Kestra Medical Technologies KMTS Stock Holding History

Citigroup’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.7K Sell
2,092
-632
-23% -$14.9K ﹤0.01% 4593
2025
Q4 		$72.2K Buy
2,724
+2,217
+437% +$57.1K ﹤0.01% 4449
2025
Q3 		$12K Sell
507
-4,132
-89% -$73.9K ﹤0.01% 4961
2025
Q2 		$76.9K Buy
4,639
+4,634
+92,680% +$101K ﹤0.01% 4546
2025
Q1 		$125 Buy
+5
New +$115 ﹤0.01% 5431

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Citigroup's KMTS Position: Q1 2026 in Review

Citigroup reduced its Kestra Medical Technologies (KMTS) stake by 23% in Q1 2026, selling an estimated $14.9K and leaving 2,092 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4593.

Citigroup first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $76.9K in Q2 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Citigroup held 2,092 shares of Kestra Medical Technologies worth $41.7K as of Q1 2026.
  • Citigroup sold 632 Kestra Medical Technologies shares in Q1 2026, an estimated $14.9K.
  • Kestra Medical Technologies made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4593 holding.
  • Citigroup first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Citigroup's Kestra Medical Technologies position peaked at $76.9K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.